Pugin J, Heumann I D, Tomasz A, Kravchenko V V, Akamatsu Y, Nishijima M, Glauser M P, Tobias P S, Ulevitch R J
Scripps Research Institute, Department of Immunology, La Jolla, California 92037.
Immunity. 1994 Sep;1(6):509-16. doi: 10.1016/1074-7613(94)90093-0.
Septic shock caused by a diverse group of bacterial pathogens is a serious human disease. Recognition of bacterial envelope constituents is one mechanism used by mammalian cells to initiate responses leading to bacterial killing or, unfortunately, responses that also cause fatal septic shock. Here we show that CD14 plays a key role in initiating cell activation by a group of bacterial envelope components from Gram-negative and Gram-positive microorganisms, as well as mycobacteria. We propose that CD14 is a receptor used by mammalian cells to recognize and signal responses to a diverse array of bacterial constituents. This finding defines the molecular basis for innate microbial immunity; implicit in these findings are new possibilities for therapeutics.
由多种细菌病原体引起的脓毒性休克是一种严重的人类疾病。识别细菌包膜成分是哺乳动物细胞用来启动导致细菌杀伤反应的一种机制,或者不幸的是,也是引发致命性脓毒性休克反应的机制。在这里,我们表明,CD14在由革兰氏阴性和革兰氏阳性微生物以及分枝杆菌的一组细菌包膜成分引发细胞活化过程中起关键作用。我们提出,CD14是哺乳动物细胞用来识别各种细菌成分并发出反应信号的一种受体。这一发现定义了先天性微生物免疫的分子基础;这些发现中隐含着治疗的新可能性。